![Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fbf962a2-ec20-4a5d-bb20-ed4c25d9db4c/gr2b_lrg.jpg)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry
![A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-07684-y/MediaObjects/41467_2018_7684_Fig1_HTML.png)
A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications
![A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-07684-y/MediaObjects/41467_2018_7684_Fig2_HTML.png)
A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia | Nature Communications
![Frontiers | Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients | Pharmacology Frontiers | Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients | Pharmacology](https://www.frontiersin.org/files/Articles/540469/fphar-11-00739-HTML-r2/image_m/fphar-11-00739-g001.jpg)
Frontiers | Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients | Pharmacology
![Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism - Huang - 2014 - Journal Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism - Huang - 2014 - Journal](https://onlinelibrary.wiley.com/cms/asset/f9c10a4b-6de1-4637-9d7d-99d5066844c3/jnc12512-fig-0002-m.jpg)
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism - Huang - 2014 - Journal
![Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/08/07/2020.08.03.20167502/F2.large.jpg)
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv
![Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study | American Journal of Psychiatry Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.2020.19121279/asset/images/medium/appi.ajp.2020.19121279f1.gif)
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study | American Journal of Psychiatry
![Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a3159b4d-9de0-414c-9409-79db5caf24d5/gr1.gif)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry
![PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial](https://i1.rgstatic.net/publication/344266112_Safety_and_cardiovascular_effects_of_multiple-dose_administration_of_aripiprazole_and_olanzapine_in_a_randomised_clinical_trial/links/5f84449a299bf1b53e20dce2/largepreview.png)